Infections are a major complication of the use of hemodialysis central venous catheters. In our study we evaluated the efficacy of the hemodialysis central venous catheter protocol management adopted in our center, through a retrospective analysis of all hemodialysis central venous catheters inserted over a period of 6 years.
Methods
Seventy-three tunneled central venous catheters and 75 temporary central venous catheters were inserted in our center from 2003 to 2008 in 148 patients.
Results
During the follow-up we observed 30 infective events (16 assessed as bacteremias, 14 subcutaneous tunnel or exit site infections) with a rate of 0.65/1,000 days of central venous catheter implantation.
Conclusions
Our experience confirms, in a 72-month follow-up, the importance of careful central venous catheter management as a crucial feature in reducing the incidence of infective events in patients with central venous catheters in dialytic treatment.
EthierJ., MendelssohnD.C, ElderS.J,. Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study.Nephol Dial transplant2008; 23: 3219–26.
2.
BeathardG.A., UrbanesA.Infection associated with tunneled hemodialysis catheters.Sem Dial2008; 21: 528–38.
KjellstrandCM., MerinoG.E., MauerSM., CasalR., Busel-MeierT.J.Complications of percutaneous femoral vein catheterisation for haemodialysis.Clin Nephrol1975; 4: 37–40.
5.
AnsellD., RoderickP., UdayarajU., van SchalkwykD., TomsonC.UK Renal Registry 11th annual report (December 2008): chapter 7: survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses.Nephron Clin Pract2009; 111: c113–39.
6.
AbbottK., AgoddaL.Y.Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States.Nephron2002; 91: 203–9.
7.
PetersonW.J., MayaI.D., CarltonD., EstradaE., AllonM.Treatment of dialysis catheter-related enterococcus bacteremia with an antibiotic lock: a quality improvement report.Am J Kidney Dis2009; 53: 107–10.
8.
AbidS., De SilvaS., WarwickerP., FarringtonK.Infective spondylodiscitis in patients on high-flux hemodialysis and on-line hemodiafiltration.Hemodialysis Intern2008; 12: 463–70.
9.
IshaniA., CollinsA.J.Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study.Kidney Int2005; 68: 311–8.
TaylorG., GravelD., JohnstonL., EmbilJ., HoltonD., PatonS.Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients.Am J Infect Control2004; 32: 399–405.
12.
JaberB.L.Bacterial infections in hemodialysis patients: pathogenesis and prevention.Kidney Int2005; 67: 2508–19.
13.
AllonM.HEMO Study.J Am Soc Nephrol2003; 14: 1863–70.
14.
LemaireX., MorenaM., Leray-MoraguésH.Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis.Blood Purif2009; 28: 21–8.
15.
BosmaJ.W., SiegertC.E.Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial.Nephrol Dial Transplant2009; 25: 1213–7.
16.
BellazziR.I rischi professionali attesi ed inattesi del nefrologo.GIN2005; 4: 376–80.
17.
JamesM.T., ConleyJ., TonelliM., MannsB.J., MacRaeJ., HemmelgarnB.R.; Alberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections.Ann Intern Med2008; 148: 596–605.
18.
TacconelliE., CarmeliY., AizerA., FerreiraG., ForemanM.G., D'AgataE.M.Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis.Clin Infect Dis2003; 37: 1629–38.
19.
FalagasM.E., BliziotisI.A., FragoulisK.N.Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials.Am J Infect Control2007; 35: 106–14.
20.
JafferY., SelbyN.M., TaalM.W., FluckR.J.A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection.Am J Kidney Dis2008; 51: 233–41.
21.
LabriolaL., CrottR., JadoulM.Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.Nephrol Dial Transplant2008; 23: 1666–72.
22.
DograG., HersonH., IrishA., HutchisonB., MoodyH. for the Perth Renal Catheter Study Group. Prevention of tunneled hemodialysis catheter related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.J Am Soc Nephrol2002; 13: 2133–9.
23.
WeijmerM.C., van den DorpelM.A., Van de VenPJG.CITRATE Study Group. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.J Am Soc Nephrol2005; 16: 2769–77.
24.
BleyerA.J.Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia.Clin J Am Soc Nephrol2007; 2: 1073–8.
25.
Al-HwieshA.K.Tunneled catheter-antibiotic lock therapy for prevention of dialysis catheter-related infections: a single center experience.Saudi J Kidney Dis Transpl2008; 19: 593–602.
26.
GerasimovskaV., OncevskiA., Gerasimovska-KitanovskaB., SikoleA.Risk of nosocomial events in patients on chronic hemodialysis: femoral vs jugular tunneled catheters [abstract]. VAS 6th international congress, April 20–22, 2009, Rome, Italy.
27.
JeanG., VanelT., BressonE.An efficient strategy to decrease the central venous catheter-related adverse events rate in hemodialysis patients [abstract]. VAS 6th international congress, April 20–22, 2009, Rome, Italy.
28.
LagaacR., JenkinsJ., DanielsC., OjhaS., PritchardN.Retrospective study of trisodium citrate 46.7% as catheter locking solution in hemodialysis patient [abstract]. VAS 6th international congress, April 20–22, 2009, Rome, Italy.
29.
BeathardG.A.Catheter management protocol for catheter-related bacteriemia prophylaxis.Semin Dial2003; 16: 403–5.
30.
National Kidney Foundation.NKF-K/DOQI: clinical practice guidelines for vascular access, update 2006. Clinical practice guidelines: 3. Cannulation of fistulae and graft and accession of hemodialysis and port catheter system; 3.4. Dialysis catheters and port system; 3.4.3. Using aseptic technique to prevent contamination of the catheter or port catheter system. Available at: http://www.kidney.org/professionals/KDOQI/guideline_upHD_PD_VA/index.htm. Accessed January 17, 2011.
31.
JeanG., VanelT., BressonE.An efficient strategy to decrease the central venous catheter-related adverse events rate in haemodialysis patients.Nephrol Ther2009; 5: 280–6.
